太龙药业: 董事和高级管理人员所持本公司股份及其变动管理制度

General Principles - The management system for the shares held by the board and senior management of Henan Tailong Pharmaceutical Co., Ltd. is established to strengthen the management of shareholding and changes in accordance with relevant laws and regulations [1][2] - The shares held by the board and senior management include all shares registered in their names and those held through others' accounts [1] Information Reporting and Disclosure - Board members and senior management must report their personal information to the company within two trading days after their appointment or any changes occur [2][3] - Prior to buying or selling company shares, board members and senior management must notify the board secretary in writing, who will verify compliance with disclosure and legal requirements [2][3] Shareholding Changes - Any changes in shareholding by board members and senior management must be reported within two trading days, including details such as the number of shares held before and after the change [3][4] - A reduction plan must be reported to the Shanghai Stock Exchange at least fifteen trading days before the first sale, with specific details on the number of shares and the time frame for the reduction [4][5] Restrictions on Share Trading - Board members and senior management are prohibited from transferring shares under certain conditions, such as within six months after leaving the company or during investigations related to securities violations [5][6] - There are specific blackout periods during which board members and senior management cannot trade shares, particularly around the announcement of financial reports [6][7] Additional Regulations - The total number of shares that can be sold by board members and senior management is limited to 25% of their holdings during their term and six months after [7][8] - The company secretary is responsible for managing the data related to shareholdings and ensuring compliance with reporting requirements [5][8]